In June 2018, the Osaka Medical College Kansai BNCT Medical Center was opened in a building with three floors aboveground and basement one floor, and a total floor area of 4,000 square meters.

Boron Neutron Capture Therapy (BNCT) uses a nuclear reaction between boron atoms (10B) and neutrons to selectively destroy cancer cells from the inside. This mechanism differs from ordinary radiation therapy, which directly kills cancer cells using an external radiation beam. As a rule, treatment is possible by single irradiation of neutron beam for 30 to 60 minutes, and the minimal side effects make this an excellent treatment. BNCT can also be expected to be effective against metastatic and refractory cancers, and it is also often used against cancers that have recurred after ordinary radiation therapy. This therapy is raising hopes as a new option for treating cancer.

At present, BNCT is undergoing clinical trials for relapsed brain tumors and head and neck cancer, and the Kansai BNCT Medical Center was born in Kansai Area where the most research results are accumulated in the world, to advance BNCT as general cancer treatment.
Today, as BNCT is in the stage of transition from the research to actual clinical treatment, the Center is collaborating with other research and related medical institutions such as the Institute for Integrated Radiation and Nuclear Science, Kyoto University. The Center is improving treatment techniques and expanding the application of this treatment to other types of cancer by the advantage of its college affiliation while working to promote clinical research.

As a dedicated Boron Neutron Capture Therapy (BNCT) facility, the Kansai BNCT Medical Center provides safe, high-quality medical care that meets the expectations of the cancer patient, while working to expand the number of cancer types to which BNCT can be applied and developing the therapy.